| ||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||
| 1. | Title: Advances in neurobiological understanding of schizophrenia. Perspectives for new therapeutic concepts
Author(s): Falkai P, Maier W Source: NERVENARZT Volume: 77 Pages: S65-S74 Supplement: Suppl. 2 Published: NOV 2006 |
| 2. | Title: Factors associated with the prodromal progression of schizophrenia that influence the course of the illness
Author(s): Bota RG, Sagduyu K, Munro JS Source: CNS SPECTRUMS Volume: 10 Issue: 12 Pages: 937-942 Published: DEC 2005 |
| 3. | Title: Feasibility of placebo-controlled clinical trials of antipsychotic compounds in Europe
Author(s): Fleischhacker WW, Burns T Source: PSYCHOPHARMACOLOGY Volume: 162 Issue: 1 Pages: 82-84 Published: JUN 2002 |
| 4. | Title: Placebo-controlled trials and active-control trials in the evaluation of new treatments - Part 2: Practical issues and specific cases
Author(s): Ellenberg SS, Temple R Source: ANNALS OF INTERNAL MEDICINE Volume: 133 Issue: 6 Pages: 464-470 Published: SEP 19 2000 |
| 5. | Title: Subject selection for the placebo- and comparator-controlled trials of neuroleptics in schizophrenia
Author(s): Mohr P, Czobor P Source: JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY Volume: 20 Issue: 2 Pages: 240-245 Published: APR 2000 |
| 6. | Title: Placebo-controlled studies in schizophrenia - ethical and scientific perspectives: an overview of conference proceedings
Author(s): Zipursky RB, Darby P Source: SCHIZOPHRENIA RESEARCH Volume: 35 Issue: 3 Pages: 189-200 Published: FEB 15 1999 |
| 7. | Title: Placebo-controlled trials: when are they needed?
Author(s): Streiner DL Source: SCHIZOPHRENIA RESEARCH Volume: 35 Issue: 3 Pages: 201-210 Published: FEB 15 1999 |
| 8. | Title: Are medication-free periods necessary for phase 3 trials of new antipsychotic drugs?
Author(s): Volavka J Source: ARCHIVES OF GENERAL PSYCHIATRY Volume: 55 Issue: 3 Pages: 280-281 Published: MAR 1998 |